Cite
MLA Citation
Peter M. Anderson et al.. “A phase II study of clinical activity of SCH 717454 (robatumumab) in patients with relapsed osteosarcoma and Ewing sarcoma.” Pediatric blood & cancer, vol. 63, no. 10, 2016, pp. 1761–1770. http://access.bl.uk/ark:/81055/vdc_100035711069.0x000015